|

6-Thio-2'-Deoxyguanosine Clinical Trials

2 actively recruiting trials

Also known as: 6-thio-dG, THIO, ateganosine

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Maia Biotechnology2

Indications

  • Carcinoma, Non-Small-Cell Lung2
  • Lung Cancer2
  • Cancer2

Other2 trials

A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Phase 3
THIO Sequenced With Cemiplimab in Advanced NSCLC
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.